These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17515288)

  • 1. Anti-atherosclerotic effect of cilostazol in apolipoprotein-E knockout mice.
    Takase H; Hashimoto A; Okutsu R; Hirose Y; Ito H; Imaizumi T; Miyakoda G; Mori T
    Arzneimittelforschung; 2007; 57(4):185-91. PubMed ID: 17515288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice.
    Chen ZF; Zhao B; Tang XY; Li W; Zhu LL; Tang CS; DU JB; Jin HF
    Chin Med J (Engl); 2011 Nov; 124(21):3460-7. PubMed ID: 22340159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-alpha formation in low-density lipoprotein receptor-null mice fed high cholesterol.
    Lee JH; Oh GT; Park SY; Choi JH; Park JG; Kim CD; Lee WS; Rhim BY; Shin YW; Hong KW
    J Pharmacol Exp Ther; 2005 May; 313(2):502-9. PubMed ID: 15734902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of PMTG on atherosclerotic lesion formation and expression of ICAM-1 and VCAM-1 in ApoE-deficient mice].
    Fang W; Zhang HX; Wang LY; Qin YW; Wu Y; Wang W; Liu B
    Zhongguo Zhong Yao Za Zhi; 2007 Jul; 32(13):1320-3. PubMed ID: 17879736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiatherogenic effect of antioxidant polyphenols from Phellinus baumii in apolipoprotein E-deficient mice.
    Noh JR; Lee IK; Kim YH; Gang GT; Hwang JH; Ly SY; Yun BS; Lee CH
    Ann Nutr Metab; 2011; 59(2-4):145-53. PubMed ID: 22142871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
    Park KY; Heo TH
    Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
    J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
    Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiatherogenic effects of cilostazol and probucol alone, and in combination in low density lipoprotein receptor-deficient mice fed with a high fat diet.
    Yoshikawa T; Mitani K; Kotosai K; Nozako M; Miyakoda G; Yabuuchi Y
    Horm Metab Res; 2008 Jul; 40(7):473-8. PubMed ID: 18404599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of felodipine suppressing atherosclerosis in high-cholesterol-diet apolipoprotein E-knockout mice.
    Yao R; Cheng X; Liao YH; Chen Y; Xie JJ; Yu X; Ding YJ; Tang TT
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):188-95. PubMed ID: 18287887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probucol and cilostazol exert a combinatorial anti-atherogenic effect in cholesterol-fed rabbits.
    Chen Y; Zhao S; Huang B; Wang Y; Li Y; Waqar AB; Liu R; Bai L; Fan J; Liu E
    Thromb Res; 2013 Nov; 132(5):565-71. PubMed ID: 24090606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse D4F, an apolipoprotein-AI mimetic peptide, inhibits atherosclerosis in ApoE-null mice.
    Qin S; Kamanna VS; Lai JH; Liu T; Ganji SH; Zhang L; Bachovchin WW; Kashyap ML
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):334-43. PubMed ID: 22308547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice.
    Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T
    Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
    Liu G; Wang B; Zhang J; Jiang H; Liu F
    J Ethnopharmacol; 2009 Nov; 126(2):350-4. PubMed ID: 19703533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
    Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
    Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice.
    Pedersen TX; Bro S; Andersen MH; Etzerodt M; Jauhiainen M; Moestrup S; Nielsen LB
    Atherosclerosis; 2009 Feb; 202(2):372-81. PubMed ID: 18489910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of atherosclerosis in apolipoprotein E-deficient mice is feasible using high-dose angiotensin receptor blocker, candesartan.
    Hayashi K; Sasamura H; Azegami T; Itoh H
    J Atheroscler Thromb; 2012; 19(8):736-46. PubMed ID: 22576470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of polygoni multiflori total glycosides on the experimentally atherosclerotic formation in apoE-deficient mice].
    Fang W; Zhang HX; Wang LY; Wu Y; Qin YW; Wang W; Du LP; Lu B
    Zhongguo Zhong Yao Za Zhi; 2005 Oct; 30(19):1542-5. PubMed ID: 16335829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.